Possible hepatosplenic candidiasis treated with liposomal amphotericin B and caspofungin combination.
Arda
Bilgin
B
Soyer
Nur
N
Sipahi
Oguz Resat
OR
Hüdaverdi
Ozcan
O
Tasbakan
Meltem Isikgoz
MI
Saydam
Guray
G
Tombuloglu
Murat
M
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy*; D000077336:Caspofungin; D054714:Echinocandins; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D055666:Lipopeptides; D008107:Liver Diseases / Q000382:microbiology*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D013158:Splenic Diseases / Q000382:microbiology*
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; C068538:liposomal amphotericin B; D000666:Amphotericin B; D000077336:Caspofungin